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Abstract
Background: The application of pulsed radiofrequency (PRF) close to the dorsal root ganglia, or peripheral nerves,
has been demonstrated to be effective for the treatment of chronic neuropathic pain conditions. The goal of this
study was to investigate the analgesic effect of immediate PRF treatment after nerve injury and its possible cellular
alterations in the dorsal horn of the spinal cord in rats with spared nerve injury (SNI).
Methods: Neuropathic pain was achieved in a SNI neuropathic pain model by ligating and cutting the
common peroneal and tibial branches of the left sciatic nerve, leaving the sural nerve intact. Wistar rats were
divided into four groups that received different treatments, i.e., SNI and PRF for 6 min at 45 V (SNI + PRF-45 V),
at 60 V (SNI + PRF-60 V), SNI alone, and sham groups. After the SNI surgery, each rat was immediately given the
PRF treatment (500 kHz, rate of 2 Hz, 20 ms duration, temperature below 42 °C) on the left sciatic nerve 0.3–0.4 cm
proximal to the injured site. The behavioral measurements included mechanical allodynia and cold allodynia of
the ipsilateral hind paw and were performed during the 28 days that followed the SNI surgery and PRF treatment.
Total extracellular signal-regulated kinase 1 and 2 (ERK1/2) and phospho-ERK1/2 were measured using Western
blot in the ipsilateral spinal cord from animals in the different groups.
Results: The three groups of rats with nerve injuries manifested a lower paw withdrawal threshold (PWT) in the
behavioral measurement of mechanical allodynia and a shorter painful-behavior duration in the cold allodynia test over
28 days. Mechanical allodynia measurement showed that both the PRF-45 V and PRF-60 V treatment groups exhibited
a more prominent antiallodynic effect than did the SNI group from days 1 to 28 after surgery. Similarly, in comparison
with the SNI group, both the SNI + PRF-45 V and SNI + PRF-60 V groups had significant inhibition on the cold allodynia
measurement from days 1 to 28 after surgery. Furthermore, the activation of the extracellular signal-regulated kinase 1
and 2 (ERK1/2) in the ipsilateral spinal dorsal horn of SNI rats was effectively inhibited in the SNI + PRF-45 V and SNI +
PRF-60 V groups for 28 days after surgery.
Conclusions: Immediate PRF application on the proximal nerve injury site provided a significant inhibition of
neuropathic pain formation, accompanied by the inhibition of ERK activation.
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Background
Neuropathic pain, which is a result of central or peripheral
nerve damage, is characterized by a complex constellation
of unusual pain symptoms, such as spontaneous and
evoked pain (allodynia and hyperalgesia) [1–3]. The clin-
ical application of all forms of pharmacotherapy pro-
vides only partial reduction of pain, and frequently
there is unsatisfactory pain relief with many unwanted
side effects [4]. Pulsed radiofrequency (PRF) treatment
was introduced in 1996 [5] and has been used as an ef-
fective therapeutic technique for chronic refractory
pains, including postamputation stump pain, cervical
and lumbar radicular pain, shoulder and knee arthro-
pathic pain, and some neuropathic pains. It has been
shown to be safe and helpful, without clinical evidence
of nerve damage compared with conventional radiofre-
quency thermocoagulation [6–14].
PRF therapy delivers a brief high-frequency elec-
trical stimulation adjacent to the dorsal root ganglia
(DRG) or a sensory nerve without causing further tis-
sue injury [15]. Aksu et al. first demonstrated that
both thermal and mechanical hyperalgesia were atten-
uated by PRF application on L5 and L6 dorsal roots in
rabbits with sciatic nerve injury (neuropathic pain
model) [16]. Perret et al. also observed that PRF pro-
vided a significant reduction of allodynia and mechan-
ical hyperalgesia for more than 32 days post-PRF
treatment delivered adjacent to the DRG in rats with
spinal nerve injury [17].
The mechanism underlying the analgesic effect of
PRF treatment remains unclear. PRF application at
DRG may alter the biological actions on synaptic
transmission, cell morphology, and Fos expression in
the superficial dorsal horn of the spinal cord, with
trivial effects on nerve tissues [18–20]. Furthermore,
PRF may augment noradrenergic and serotonergic
descending inhibitory systems within the spinal cord,
which afforded an analgesic effect in an inflamma-
tory pain model [21]. Evidence has shown that extra-
cellular signal-regulated kinase (ERK) plays a
decisive role in regulating inflammatory responses
and neuropathic pain [22, 23]. A recent study also
reported that ERK knockout mice exhibited de-
creased pain sensitization after formalin stimulation
or partial sciatic nerve ligation [24]. Thus, inhibition
of ERK activation may be a promising therapeutic
target for the treatment of neuropathic pain [25–27].
In the present study, we examined the analgesic ef-
fect of PRF treatment at the usual clinical conditions
(PRF waves with a 500 kHz frequency, 45 or 60 V
output, and 20 ms pulse width; delivered for 6 min)
and the relationship between PRF and ERK1/2 ex-
pression in the dorsal horn of the spinal cord in rats
with spared nerve injury (SNI).
Methods
Animals, Setting, and Ethics
This study was approved by the Animal Care and Use
Committee of the National Defense Medical Center
(Taipei, Taiwan, Republic of China) and was conducted
in accordance with the Guide for the Care and Use of
Laboratory Animals published by the National Institutes
of Health (Bethesda, Maryland).
Male Wistar rats (BioLASCO, Taipei, Taiwan) weigh-
ing 200–250 g were housed individually with soft bed-
ding in a 12 h night/day cycle with free access to food
and water at all times in a similar environment for
7 days, for acclimation before SNI surgery. All efforts
were made to minimize the number of animals used and
their suffering. Rats were randomly divided into four
groups that were treated with or without PRF for 6 min
(3 min per session, with a 30 s intersession interval):
SNI + PRF-45 V group, SNI + PRF-60 V group, SNI
group (RF needle was put on but no current was deliv-
ered), and sham-operated + placebo PRF group. Animals
were assessed for mechanical allodynia using dynamic
plantar aesthesiometry (DPA) and for cold allodynia using
the acetone spray test 1 day before surgery (baseline),
without clinical evidence of nerve damage or various days
(at day 1 (D1), D3, D7, D10, D14, D21, and D28) after sur-
gery, as indicated in the single PRF treatment.
Neuropathic pain Model
The neuropathic pain model was induced by SNI de-
scribed by Decosterd and Woolf [28]. SNI was per-
formed under 1.5 % isoflurane (Halocarbon, NJ, USA)
anesthesia. A 2–4 mm ligated nerve of the common
peroneal and tibial branches of the left sciatic nerve was
removed, and sural nerve was left intact. Sham surgery
refers to the same protocol but without nerve injury.
Assessment of Antinociception to Pulsed Radiofrequency
All rats were randomly divided into four groups (n = 7
for each group). PRF was administered via an electro-
cautery disk placed in a right decubitus position and
connected to the PRF generator (NeuroTherm, NT1000,
UK). The 5 mm active tip electrode (NeuroTherm 22
GA) was placed vertically, adjacent to the left sciatic
nerve (0.3–0.4 cm proximal to the injury site) immedi-
ately after the SNI surgery (Fig. 1). PRF treatment
(500 kHz) with an output of 45 or 60 V or no output
was delivered at a rate of 2 Hz, 2 bursts/s with a 20 ms
duration for 6 min at a temperature below 42 °C. The
SNI group and sham-operated + placebo group were
used as controls, respectively. The former was achieved
by placing the electrode 0.3–0.4 cm proximal to the in-
jury site, whereas the latter was performed by placing
the electrode on an intact sciatic nerve. The procedures
performed in both groups were identical to those used
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in the PRF treatment groups, but without application of
an electric current. The probe was lightly placed in a
perpendicular direction to the sciatic nerve, and the
temperature of the tip of the electrode was controlled
below 42 °C. At the end of the procedure, the skin inci-
sion was closed with 4-O silk sutures, and the animal
was allowed to recover from anesthesia.
Behavioral Testing of Tactile Allodynia
Mechanical allodynia was examined using a dynamic
plantar aesthesiometer (DPA; Ugo Basile, Comerio,
Italy), which is an automated version of the von Frey
filament that does not produce tissue damage [29, 30].
According to the Kyoto protocol of the International As-
sociation for the Study of Pain, Basic Pain Terminology,
the DPA produces non-noxious tactile stimuli [31]. Each
rat was placed in an individual plastic cage (25 cm
long × 10 cm wide × 14 cm high) with a wire mesh floor,
was acclimatized to the cage for 15 min before each test
session, and a paw withdrawal response was elicited by
applying an increasing force using a blunt-end metal fila-
ment (0.5 mm in diameter) focused on the territory of
the sural nerve at the palmar surface of the left ipsilat-
eral hind paw. The force was increased from 1 to 50 g in
steps of 1 g over 20 s, and was then held at 50 g for an
additional 10 s; the rate of the force increase was 2.5 g/s.
The threshold was recorded as the force that elicited the
hind paw removal reflex (the mean of three measure-
ments performed at 1 min intervals).
Cold Allodynia Behavioral Testing
Cold hypersensitivity was determined by measuring the
cold withdrawal response of the hind paw to an acetone
spray. Rats were placed in a transparent plastic cage on
top of a wire mesh grid, which allowed access to the
paws, and were adapted to the testing environment for
15 min before the measurement was performed. Cold
allodynia was assessed by spraying acetone (100 μL)
using an Eppendorf multistepper pipette onto the pal-
mar surface of the ipsilateral hind paw through the wire
mesh floor, and the duration of shaking, flinching, biting,
or licking behavior that ensued in a 1 min period was
measured [32, 33]. Each rat was tested five times with a
minimal interval of 5 min. A minimal value of 0.5 s was
given if there was a fast or brisk reaction, whereas a
value of 0 was given if no reaction was observed at all.
Spinal Cord Preparation and Western Blotting Analysis
All rats underwent behavioral tests of mechanical allody-
nia and cold allodynia and were killed immediately after
the tests, at different days of completion. The rats were
rapidly decapitated and the left dorsal quadrant of the
lumbar spinal cord enlargement was removed and stored
at −80 °C until use. Tissue samples from the L4–L6 dor-
sal horns were lysed by homogenizing in 200 μL of lysis
buffer (30 mM Tris, 2 M thiourea, 7 M urea, 4 %
CHAPS, protease inhibitor cocktail (Merck 1:100), and
phosphatase inhibitor cocktail set V (Merck 1:50) ad-
justed to pH 7.4 with HCl). Lysates were centrifuged at
20,000× g for 20 min at 4 °C and the protein concentra-
tion in each sample (supernatant) was determined using
the 2-D Quant kit (GE Healthcare). Samples with an
equal amount of protein were then separated by SDS–
PAGE and transferred to PVDF membranes (Millipore,
Bedford, MA). The membranes were blocked with
blocking buffer (20 mM Tris–HCl, pH 7.5, 150 mM
NaCl, and 5 % skim milk) for 1 h at room temperature
with gentle shaking, followed by washing with TNT buffer
(20 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 0.05 %
Tween 20) and overnight incubation at 4 °C with mouse
anti-p-ERK antibodies (Santa Cruz Biotechnology) diluted
at 1:200 in TNT buffer. After washing with TNT buffer,
the membranes were incubated for 1 h at room
temperature with an HRP-conjugated anti-mouse IgG
antibody (BD Biosciences Pharmingen). Bands were
visualized using enhanced chemiluminescence reagents
(Millipore), and images were recorded on a computer
using the UVP Bioimaging System (UVP, Upland, CA,
USA). After stripping, the membranes were reprobed
with rabbit anti-ERK antibodies (Santa Cruz Biotech-
nology) diluted at 1:200 in TNT buffer. The
membranes were then incubated for 1 h at room
temperature with an HRP-conjugated anti-rabbit IgG
antibody (GeneTex Inc.). The final detection was per-
formed as described above.
Statistical Analyses
Data are presented as the mean ± standard deviation
(SD). We used linear contrasts to calculate P values. The
first contrast was used to compare the “SNI effect”: we
set the assign coefficients as 1, −1/3, −1/3, and −1/3 for
the sham, SNI, SNI + PRF-45 V, and SNI + PRF-60 V
Fig 1 Application of pulsed radiofrequency (PRF) in a model of
spared nerve injury (SNI). a. Diagram. b. Actual application of PRF
immediately after SNI surgery
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groups, respectively. The second contrast was used to
compare the “treatment effect”: we set the assign coeffi-
cients as 0, −1, −1/2, and −1/2, respectively. The third
contrast was used to compare the “dosage effect”: we set
the assign coefficients as 0, 0, 1, and −1, respectively.
Data pertaining to the relative density of western blot
bands were analyzed by one-way ANOVA, followed by
multiple comparisons using the Student–Newman–
Keuls post hoc test. Data from behavioral tests are pre-
sented as the mean ± SD. Data pertaining to the quanti-
tative densitometry of the pERK1/2 to ERK1/2
expression ratio were expressed as the mean ± standard
error of the mean (SEM). We considered P < 0.05 as sig-
nificant in all analyses. Statistical analyses were carried
out using the R3.1.1 software (“multicom” package).
Results
No differences were observed between the four groups
relative to the basal values of left hind paw behavioral
tests in response to mechanical stimulus or acetone
spray (P > 0.05; as listed in Figs 2 and 3). First, to investi-
gate the “SNI effect”, we compared the three groups
(SNI, SNI + PRF-45 V, and SNI + PRF-60 V) of rats with
nerve injuries with the sham group and found that the
sham group had a significantly lower paw withdrawal
threshold (PWT) (P1 < 0.001; Fig. 2) and a longer
painful-behavior duration (P1 < 0.001; Fig. 3) in two dif-
ferent behavioral measurements over 28 days. Second,
we investigated the “treatment effect” by recording the
left hind paw responses to mechanical stimulus and
observed that both the SNI + PRF-45 V and SNI + PRF-
60 V treatment groups had a significantly greater antial-
lodynic effect compared with the SNI group from days 1
to 28 after surgery (D1–D21, P2 < 0.001; D28, P2 < 0.05;
Fig. 2). For the left hind paw responses in the acetone
spray test, we found that rats in both the SNI + PRF-
60 V and SNI + PRF-45 V groups had a significantly
shorter painful-behavior duration than did SNI rats from
days 1 to 28 (P2 < 0.001; Fig. 3). Third, during an explor-
ation of the “dosage effect,” we observed no significant
differences in the mechanical and cold hypersensitivity
at all time points between the SNI + PRF-45 V and SNI
+ PRF-60 V groups (P3 > 0.05; Figs 2 and 3). No neur-
opathy was found in the sham-operated groups.
The Western blot analysis of pERK1/2 and total
ERK1/2 in the ipsilateral spinal cord at day 28 in the
four groups (sham-operated control, SNI, SNI + PRF-
45 V, and SNI + PRF-60 V) revealed an activation of
ERK1 and ERK2 in the ipsilateral spinal dorsal horn of
SNI rats, which was effectively reduced at day 28 in the
SNI + PRF-45 V and SNI + PRF-60 V groups (Figs 4a, b).
Figure 4a shows that total ERK1/2 expression exhibited
no significant changes in all groups. In contrast,
Fig 2 Paw withdrawal test of mechanical allodynia. The paw withdrawal threshold in rats that were subjected to the sham operation, SNI without
PRF (SNI group), or SNI plus either 45 V PRF or 60 V PRF (SNI + PRF-45 V and SNI + PRF-60 V groups, respectively). Mechanical allodynia was
evaluated using dynamic plantar aesthesiometry. The data presented above were examined by ANOVA followed by Bonferroni test. D, day.
#P < 0.05, ##P < 0.01 SNI, SNI + PRF-45 V, and SNI + PRF-60 V compared with the sham. *P < 0.05, **P < 0.01 SNI + PRF-45 V and SNI + PRF-60 V
compared with SNI
Fig. 3 Paw withdrawal test of cold allodynia. Behavioral response in
rats subjected to sham operation or SNI without PRF (SNI group) or
SNI plus either 45 V PRF or 60 V PRF (SNI + PRF-45 V and SNI + PRF-
60 V groups, respectively). Cold allodynia was evaluated by the
acetone spray test. The data presented above were examined by
ANOVA followed by Bonferroni test. D, day. #P < 0.05, ##P < 0.01 SNI,
SNI + PRF-45 V, and SNI + PRF-60 V compared with the sham. *P <
0.05, **P < 0.01 SNI + PRF-45 V and SNI + PRF-60 V compared
with SNI
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activated pERK1/2 was significantly increased after nerve
injury in the SNI group, whereas a significant decrease
in pERK1/2 levels was observed in the SNI + PRF-45 V
and SNI + PRF-60 V groups at day 28. Figure 4b shows
the ratio of the levels of pERK1/2 and total ERK1/2 (n =
4–6/group, *P < 0.05 compared with the sham control,
PRF-45 V-treated, or PRF-60 V-treated rats). There was
a 2.3-fold increase in the levels of activated p-ERK after
SNI compared with the sham group, whereas the in-
crease in ERK phosphorylation was inhibited by 44.74 %
and 45.37 % after immediate PRF-45 V and PRF-60 V
treatments compared with the SNI group, respectively.
Discussion
In our study, immediate PRF treatment after SNI signifi-
cantly alleviated the mechanical and cold allodynia in
rats with SNI. After both the PRF-45 V and PRF-60 V
treatments for 6 min, mechanical allodynia and cold
hypersensitivity were reduced during the 28-day obser-
vation. Furthermore, we investigated the “dosage effect”
of PRF treatment and found no significant differences in
the mechanical and cold hypersensitivity at any time
point between the SNI + PRF-45 V and SNI + PRF-60 V
groups. PRF has been used widely for neuropathic pain
management in clinical treatments, and a long-term
effect has been observed after a single PRF application
[34, 35]. In preclinical studies performed using a neuro-
pathic pain model in the rabbit (induced by partial sci-
atic nerve ligation), both thermal and mechanical
hyperalgesia were attenuated for 2 and 3 weeks after
PRF application at 40–60 V for 8 min to the L5 and L6
dorsal roots [16]. In an L5 spinal nerve ligation neuro-
pathic pain model in the rat, PRF attenuated mechanical
allodynia for more than 32 days after a single PRF treat-
ment at 25 V for 2 min adjacent to DRG [17]. Further-
more, PRF application at 45 V for 3 min on DRG yielded
a reduction of mechanical hypersensitivity in rats with
L5 spinal nerve ligation (SNL) and transaction [36]. In
our study, immediate PRF was effective in alleviating the
SNI-induced neuropathic pain. In particular, we ob-
served that PRF treatment at 45 or 60 V for 6 min in-
duced a similar antinociceptive effect for SNI that lasted
up to 28 days.
In our examination, we found that allodynia developed
at day 1 after SNI. Immediate PRF treatment after SNI
resulted in a better anti-allodynia effect than that after
14 days of SNI (data not shown). It suggests that imme-
diate PRF application takes only one times surgery and
might inhibit severe immune response, providing better
anti-allodynia effect with less undesirable side effects,
such as adhesion and bleeding, than PRF treatment after
14 days of SNI. Furthermore, an animal study showed
that even percutaneous application of PRF 50 V for 2 or
6 min provided a significant anti-allodynia effect in SNL
rats [37]. Our study is the first to apply immediate treat-
ment on the left sciatic nerve 0.3-0.4 cm proximal to the
injured site in SNI rats. In addition, we further found
that 60 V PRF treatment showed no better anti-allodynia
effect than 45 V PRF during 28-day-observation. Ac-
cordingly, for PRF interventional treatments in radicular
pain, it is advisable to choose the 45 V treatment, as the
lower-voltage therapy produces less adverse effects while
attaining similar benefits.
The application of PRF for the management of neuro-
pathic pain should be considered carefully, as the mech-
anisms involved in the immediate versus the delayed
phase may differ, and the immediate early phase of nerve
injury is less understood. PRF for the management of
clinical chronic neuropathic pain is common; however,
sometimes it fails to provide a satisfactory effect, with
the delayed intervention being one of the possible expla-
nations for this finding. In the case of acute nerve injury,
the acute inflammatory process without proper interven-
tion often results in chronic neuropathic pain [38]. Lin
et al. found that early PRF treatment suppressed the
levels of proinflammatory cytokines via neuromodula-
tion and immune modulation, such as the downregula-
tion of spinal MAPK (ERK) activation [39]. Therefore,
we assumed that an immediate or early PRF intervention
may result in less neuroinflammation compared with a
delayed PRF intervention.
In clinical practice, the application of immediate PRF
therapy for the management of acute nerve injury might
Fig 4 Effect of pulse repetition frequency on ERK1/2 expression in the
spinal dorsal horn of rats with spared nerve injury. A. Representative
Western blot showing upregulation of pERK1/2 and total ERK1/2 in the
ipsilateral spinal cord at day 28 in various conditions (sham-operated
control, SNI, and SNI + PRF-45 V). B. Histograms showing the results of
a quantitative densitometric analysis of the pERK1/2 to ERK1/2
expression ratio. n = 4–6/group, *P < 0.05 compared with the sham
control or PRF-45 V-treated rats. The data are expressed as the mean ±
SEM. Differences between experimental groups were assessed by one-
way ANOVA followed by Newman–Keuls multiple comparisons
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encounter several difficulties. Most patients will choose to
undergo nerve reconstruction operation to restore neuro-
logical function. For those who cannot or will not undergo
surgery, we propose an alternative, immediate/early PRF,
to achieve a better effect, even though this study is still in
the animal experiment stage. Nevertheless, to our know-
ledge, there is no clinical research-based investigation of
the difference in antiallodynic effect between immediate
and delayed PRF therapy after acute nerve injury. To
translate our findings into future treatment strategies for
developing neuropathic pain, we may choose to apply PRF
treatment immediately, or combine one immediate and
one delayed application of PRF to provide optimal results
for patients.
The mechanisms underlying the effect of PRF treat-
ment have not been well defined. It is thought to occur
via a neuromodulatory effect that interferes with sensory
neuron-specific molecules and gene expression involved
in neuropathic pain development [36]. In other studies,
RF stimulation at DRG altered synaptic transmission
and cell morphology and induced Fos expression in the
superficial dorsal horn, which suggests that this type of
stimulation increases spinal neuron activity [18–20, 40].
The expression of ERK in DRG and the dorsal horn has
been suggested to be a major target of mitogen-activated
protein kinases (MAPKs) in the treatment of neuro-
pathic pain. Suppression of ERK activation may be a
promising therapeutic aim for the treatment of this type
of pain [25–27]. Moreover, ERK was shown to be se-
quentially activated in different cell types in the dorsal
horn of the spinal cord 21 days after the nerve injury in
animals with SNL neuropathic pain [41]. Géranton et al.
also demonstrated that SNI induces ERK activation in
the dorsal horn of the spinal cord [42]. Similar to the re-
sults described here, activation of the phosphorylation of
ERK1 and ERK2 in the ipsilateral spinal dorsal horn of
SNI rats was found to be increased by 2.3-fold compared
with the sham group. We also found that the increase in
the phosphorylation of ERK1/2 observed after SNI was
effectively inhibited (by 44.74 %) by immediate PRF ther-
apy at 45 V at postsurgery day 28. Accordingly, we con-
clude that the analgesic effect of PRF may be attributed
to its inhibitory effect on ERK activation in dorsal horn
cells. Furthermore, in rats with neuropathic pain, the
application of PRF on DRG attenuated SNL and
transaction-induced neuropathic pain, with attenuation
of microglial expression in the spinal dorsal horn [36].
Similarly, Lin et al. demonstrated that PRF inhibited
ERK activation, which was detected on the third day
after surgery [39]. Taken together, our results strongly
suggest that immediate PRF treatment regulates ERK-
mediated mechanisms in the spinal dorsal horn of SNI
rats, which in turn reduces SNI-induced neuropathic
pain. Accumulating evidence shows that the activation
of MAPKs (p38, ERK, and JNK) can induce the synthesis
of proinflammatory/pronociceptive mediators via dis-
tinct molecular and cellular mechanisms, resulting in
the enhancement and prolongation of pain. Another
study indicated that early application of PRF adjacent to
the DRG significantly diminished nerve ligation-induced
mechanical allodynia for 7 days and thermal hyperalgesia
on postoperative days 3–7 by downregulating p38 and
ERK activation [39]. However, the long-term effect of
PRF on analgesia remains unknown. Interestingly, nerve
injury activates ERK in microglia and astrocytes, as
observed in the early (days) and late (weeks) phases, re-
spectively [22]. Therefore, we investigated the long-term
effects of PRF on ERK activation. Other investigators
also found a similar long-term efficacy of continuous
PRF-DRG in the treatment of chronic pain in humans,
and reported that PRF-DRG treatment had an analgesic
effect that ranged from weeks to over 6 months, afford-
ing over 50 % pain relief [43, 44]. Clearly, further investi-
gation is required to understand the cell types in the
dorsal horns that are involved in this effect and the role
of ERK in the regulation of allodynia and hyperalgesia.
Conclusions
Immediate application of PRF at 45 or 60 V on the prox-
imal (0.3–0.4 cm) nerve injury site was an effective treat-
ment for the management of neuropathic pain; the
treatment was associated with an inhibition of ERK ac-
tivity. For clinical translation, well-designed randomized
controlled trials are required to identify the beneficial ef-
fect of PRF treatment proximal to the nerve injury site.
Additional studies of the effect of PRF on the expression
of ERK should be performed to provide evidences in
treating neuropathic pain.
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